- Home
- FSP vs CYBN Comparison
FSP vs CYBN Comparison
Compare FSP & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSP
- CYBN
- Stock Information
- Founded
- FSP 1981
- CYBN 2019
- Country
- FSP United States
- CYBN Canada
- Employees
- FSP N/A
- CYBN N/A
- Industry
- FSP Real Estate Investment Trusts
- CYBN Pharmaceuticals and Biotechnology
- Sector
- FSP Real Estate
- CYBN Health Care
- Exchange
- FSP Nasdaq
- CYBN Nasdaq
- Market Cap
- FSP 166.9M
- CYBN 176.0M
- IPO Year
- FSP N/A
- CYBN N/A
- Fundamental
- Price
- FSP $1.70
- CYBN $7.11
- Analyst Decision
- FSP
- CYBN Strong Buy
- Analyst Count
- FSP 0
- CYBN 3
- Target Price
- FSP N/A
- CYBN $85.00
- AVG Volume (30 Days)
- FSP 330.5K
- CYBN 351.0K
- Earning Date
- FSP 07-29-2025
- CYBN 08-13-2025
- Dividend Yield
- FSP 2.47%
- CYBN N/A
- EPS Growth
- FSP N/A
- CYBN N/A
- EPS
- FSP N/A
- CYBN N/A
- Revenue
- FSP $111,879,000.00
- CYBN N/A
- Revenue This Year
- FSP $4.36
- CYBN N/A
- Revenue Next Year
- FSP $0.81
- CYBN N/A
- P/E Ratio
- FSP N/A
- CYBN N/A
- Revenue Growth
- FSP N/A
- CYBN N/A
- 52 Week Low
- FSP $1.36
- CYBN $4.81
- 52 Week High
- FSP $2.21
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- FSP 56.64
- CYBN 45.43
- Support Level
- FSP $1.60
- CYBN $6.36
- Resistance Level
- FSP $1.70
- CYBN $7.75
- Average True Range (ATR)
- FSP 0.06
- CYBN 0.34
- MACD
- FSP 0.01
- CYBN -0.04
- Stochastic Oscillator
- FSP 85.71
- CYBN 51.95
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.